Results 141 to 150 of about 6,382 (203)

Antimicrobial resistance and virulence of Enterococcus faecium isolates from a traditionally fermented dairy beverage from Uganda. [PDF]

BMC Microbiol
Byakika S, Mukisa IM.
europepmc   +1 more source

The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals. [PDF]

Genes (Basel)
Singam H, Mossad S.
europepmc   +1 more source

Drug-Drug Interactions in Recently Approved Antibacterials: A Mini Review. [PDF]

Eur J Drug Metab Pharmacokinet
Baccari I, Bergmann F, Zeitlinger M.
europepmc   +1 more source

Rifamycins [PDF]

, 2015
Melanie Jane Maslow, Cynthia Portal-Celhay   +1 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Rifamycins – Obstacles and opportunities

Tuberculosis, 2010
With nearly one-third of the global population infected by Mycobacterium tuberculosis, TB remains a major cause of death (1.7 million in 2006). TB is particularly severe in parts of Asia and Africa where it is often present in AIDS patients. Difficulties in treatment are exacerbated by the 6-9 month treatment times and numerous side effects.
George A Garcia, Paul D Kirchhoff, H D Hollis Showalter   +2 more
exaly   +3 more sources

Rifamycins [PDF]

, 2001
core   +5 more sources

Allosteric Modulation of the RNA Polymerase Catalytic Reaction Is an Essential Component of Transcription Control by Rifamycins [PDF]

Cell, 2005
SummaryRifamycins, the clinically important antibiotics, target bacterial RNA polymerase (RNAP). A proposed mechanism in which rifamycins sterically block the extension of nascent RNA beyond three nucleotides does not alone explain why certain RNAP ...
Irina Artsimovitch, Marina N Vassylyeva, Dmitri Svetlov   +2 more
exaly   +2 more sources

Rifamycins [PDF]

, 2010
Francesco. Parenti, Giancarlo. Lancini
core   +5 more sources

Rifamycins [PDF]

, 1967
Laura Frontali, Giorgio Tecce
core   +4 more sources